Flu vaccinal prevention in modern conditions

Abstract

The article highlights the socio-economic burden of influenza associated with significant morbidity and complications, most often recorded in risk group patients. The basic categories of patients to pass fl u vaccination first are underlined. The classification of current seasonal influenza vaccines is presented. The data of studies examining the immunogenicity, efficacy and safety of the seasonal flu vaccine Fluarix™ are presented.